Reyataz label, Evotaz label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Drug 2 dose
200 mg PO Q12H
Drug 2 effect
Voriconazole AUC decreased 39% when given with ritonavir 100 mg BID
Clinical Effects
Potential decreased voriconazole antifungal effects
Management
With unboosted atazanavir no dose adjustment necessary, monitor for toxicity. Do not coadminister with boosted protease inhibitors unless benefit outweighs risks. Consider therapeutic drug monitoring.
Import ID
863
